Mona Shahriari, MD, hosted a Case-Based Roundtable discussion to review 2 challenging cases of atopic dermatitis in patients with skin of color.
The experts discuss combination therapy approaches, safety considerations, and targeted interleukin-17 systemic treatments for plaque psoriasis.
The COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.
Brella received FDA clearance last week for improving excessive underarm sweating.
An expert in dermatology discusses the intricacies of addressing anti-aging concerns in patients with diverse skin tones, emphasizing the importance of tailoring management to meet their unique needs, understanding the underlying mechanisms of aging, and appreciating the cultural nuances within patient populations.
Explore various elements that can go into a comprehensive insurance benefits package for dermatology practice employees.
Take a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.
Looking to the future of atopic dermatitis treatment, Drs Kiracofe and Murase offer concluding remarks on current unmet needs, the benefits of treatment guidelines, and the importance of treating itch in patients who are or may become pregnant.
As co-director, Biesman is looking forward to all attendees being able to find medical and aesthetic sessions relevant to their education.
Laura Rezac, MD and her colleagues evaluated a teledermatology postoperative follow-up model after Mohs Micrographic surgery.
"It's an exciting time" in dermatology, said Lee, who reflects on late-breaker data and other research presented at the 2024 AAD Annual Meeting.
Regional disparities were highlighted in a study of inpatient dermatology encounters, locations, and providers from 2013 to 2019.
Superficial radiation offers a newer, FDA-approved office-based option that is safe. Steven A. Davis, M.D., shares his experience using surface radiotherapy to treat his patients with non-melanoma skin cancer.
Maggi Ahmed, MD, PhD, demonstrated superior pigmentation outcomes and reduced CD8+ T cell numbers in her recent research results.
In the final part of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.
It is crucial to better understand, diagnose, and manage this skin condition associated with significant quality-of-life impairment.
Neoadjuvant treatment with cemiplimab led to near or complete disappearance of cutaneous squamous cell carcinoma in almost 64% of patients set to undergo surgery.
Patient Cole Villaflor, his mother, and Michael Levy, MD, PhD, provide insights into Cole’s hyperhidrosis diagnosis and subsequent endoscopic thoracic sympathectomy surgery.
DermTech’s study results demonstrated that in patients with Fitzpatrick skin types IV-VI, all 3 melanomas diagnosed by histopathology were correctly identified by the 2-GEP assay as positive for LINC00518 and PRAME.
Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.
Dermatologist Laura Ferris, MD, PhD, discusses skin-related toxicities as a result of immunotherapies for the treatment and management of cancers.
Medical practices must go beyond simply offering competitive salaries and benefits packages to attract new talent and keep their best clinicians and administrative staff working for them.